NEWS

May 2022

  • May 20, 2022

    NOTICE OF THE 159TH ANNUAL GENERAL MEETING OF SHAREHOLDERS

  • May 19, 2022

    FY2021 Operating Results & Financial Position

  • May 18, 2022

    Bench-Top X-Ray Computed Tomography (CT) System Allows Anyone to Perform Examinations Immediately
    Release of XSeeker 8000, the World’s Smallest, Lightest 160 kV Output Model

  • May 12, 2022

    A Shimadzu Group American Sales Subsidiary Recognized as a “Great Place to Work”

  • May 10, 2022

    Earnings Report for the fiscal year ended March 31, 2022

  • May 10, 2022

    Notice Regarding Dividends of surplus

  • May 10, 2022

    Fact Book 2022, DATABOOK

April 2022

  • April 27, 2022

    Pretreatment Systems for Analytical Instruments, TOF-PET System, and Shimadzu Brand Experience Exhibit Receive “iF Design Award 2022.”

  • April 26, 2022

    Using the World’s First AI-Enhanced Cutting-Edge Image Processing System
    Release of New Angiography System that Supports Catheterization Procedures Performed throughout the Body for Cardiac and Other Diseases

  • April 26, 2022

    Shimadzu Corporation Announces Strategic Partnership with TetraScience
    Partnership Reflects Commitment to Help Customers Maximize the Value of their Scientific Data Through TetraScience’s Open Cloud Ecosystem

  • April 21, 2022

    The reduction in greenhouse gas emissions from the carbonization of wood debris has been evaluated for the first time.

  • April 15, 2022

    Shimadzu Group Sets New CO2 Emission Reduction Targets
    Moving toward net zero CO2 emissions from overall business activities by 2050

  • April 13, 2022

    Two Shimadzu Pretreatment Systems for Analytical Instruments Receive Red Dot Awards
    —Red Dot Design Award 2022—

  • April 12, 2022

    Osaka University, Shimadzu, and SIGMAXYZ Collaborate on 3D Bioprinting Technology
    ~Accelerating technological development to solve social issues such as the environment, food, and health~

  • April 8, 2022

    Shimadzu Review Vol.78[1・2] Industrial Machinery

  • April 7, 2022

    AI (Artificial Intelligence) Incorporates the Skills of a Highly Experienced Operator to Provide easy-to-interpret Tomosynthesis Images with Ease
    Release of New Software for the Multi-purpose Digital R/F System SONIALVISION G4

  • April 6, 2022

    Contributing to CO2 Reduction and Carbon-Neutrality
    Participation in Experiment with Kyoto University and Others to Demonstrate Using Marine Photosynthetic Bacteria for Carbon Dioxide Fixation

  • April 1, 2022

    Reduce Costs, System Downtime, and CO2 Emissions by 60 % with a System Upgrade
    Release of the Autograph X-V Retrofit Partial Upgrade Kit for Precision

March 2022

  • March 22, 2022

    For the Sixth Consecutive Year, Shimadzu was Selected as a Nadeshiko Brand that Actively Empowers Women within the Company

  • March 18, 2022

    Release of the New IRXross Fourier Transform Infrared Spectrophotometer, Featuring High Functionality and High Usability

  • March 9, 2022

    Selected as a “Health and Productivity Management Brand” for the Second Consecutive Year
    Recognized as “White 500” Company with Superior Health Management Practices

  • March 4, 2022

    Verification Testing Started with AI Startup Epistra for Joint Development of Solution for Optimizing Cell Culturing Parameters

February 2022

  • February 25, 2022

    Notice of Changes in Excecutive Members

  • February 24, 2022

    Q&A session Transcript(summary)

  • February 22, 2022

    Growth Strategy for Analytical & Measuring Instruments Business

  • February 22, 2022

    New Turbomolecular Pump Model Reduces Environmental Impact
    TMP-V4404LMW Released for Thin-Film Coating

  • February 16, 2022

    Rakuten Medical and Shimadzu Enroll First Patient in the U.S. Clinical Trial of Photoimmunotherapy
    - Phase 2 Clinical Trial, ASP-1929 Photoimmunotherapy with Fluorescence Imaging for Operable Primary or Recurrent Head and Neck or Cutaneous Squamous Cell Carcinoma -

  • February 15, 2022

    3rd Quarter Results & Financial Position for the Fiscal Year Ended March 2022

  • February 8, 2022

    SHIMADZU and SHIONOGI establishes joint venture AdvanSentinel
    - Solving social issues via public health risk assessment, including wastewater surveillance -

  • February 4, 2022

    Earnings Report for the nine months ended December 31, 2021

  • February 4, 2022

    DATABOOK

  • February 3, 2022

    Expanding Market Share in the Pharma/Biopharma Market with New LC
    Release of the Nexera XS inert High-Performance Liquid Chromatograph

  • February 1, 2022

    Regarding the Apache Log4j Security Vulnerability

January 2022

  • January 31, 2022

    Appointment of New Chairman of the Board and New President & CEO

  • January 26, 2022

    Supporting More Efficient Aroma-Related Development and Evaluation
    Release of Aroma Analysis Software for GC-MS

  • January 24, 2022

    MALDI-8030: Shimadzu adds further versatility to existing class-leading line up of MALDI-TOF Mass Spectrometers

  • January 12, 2022

    Integrating Fluoroscopy Room and Radiography Room into One.
    Release of FLEXAVISION F4 package with FPD Capable of both Fluoroscopy and Wireless Radiography

  • January 6, 2022

    Using Biotechnology and Digital Technology to Further Contribute to Achieving a Carbon-Free Society
    Investment in Kobe University Startup Company Bacchus Bio innovation Co., Ltd.

May 2022

April 2022

March 2022

February 2022

January 2022

May 2022

April 2022

March 2022

February 2022

January 2022